{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:57:33Z","timestamp":1792015053253,"version":"4.4.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/inf.0b013e31824e10d7","type":"journal-article","created":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T09:15:22Z","timestamp":1328865322000},"page":"464-468","source":"Crossref","is-referenced-by-count":48,"title":["Defining Risk Factors for Red Man Syndrome in Children and Adults"],"prefix":"10.1097","volume":"31","author":[{"given":"Angela L.","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gaedigk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura P.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridgette L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Neville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 1","key":"R1-9-20210202","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history.","volume":"42","author":"Levine","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R2-9-20210202","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1128\/JCM.01388-06","article-title":"Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period.","volume":"44","author":"Wang","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R4-9-20210202","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/infdis\/168.3.773","article-title":"Prospective evaluation of red man syndrome in patients receiving vancomycin.","volume":"168","author":"OSullivan","year":"1993","journal-title":"J Infect Dis"},{"key":"R5-9-20210202","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/AAC.36.6.1204","article-title":"Absence of red man syndrome in patients being treated with vancomycin or high-dose teicoplanin.","volume":"36","author":"Rybak","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"R6-9-20210202","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1542\/peds.86.4.572","article-title":"Vancomycin-induced red man syndrome.","volume":"86","author":"Levy","year":"1990","journal-title":"Pediatrics"},{"key":"R7-9-20210202","first-page":"17","article-title":"Adverse reactions to vancomycin used as prophylaxis for CSF shunt procedures.","volume":"138","author":"Odio","year":"1984","journal-title":"Am J Dis Child"},{"key":"R8-9-20210202","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-3476(80)80347-7","article-title":"Clinical pharmacology and efficacy of vancomycin in pediatric patients.","volume":"96","author":"Schaad","year":"1980","journal-title":"J Pediatr"},{"key":"R10-9-20210202","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.2005-2429","article-title":"Adverse drug reactions among children over a 10-year period.","volume":"118","author":"Le","year":"2006","journal-title":"Pediatrics"},{"key":"R11-9-20210202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R12-9-20210202","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1211\/0022357001773878","article-title":"Histamine release induced by antimicrobial agents and effects of antimicrobial agents on vancomycin-induced histamine release from rat peritoneal mast cells.","volume":"52","author":"Toyoguchi","year":"2000","journal-title":"J Pharm Pharmacol"},{"key":"R14-9-20210202","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/infdis\/157.3.502","article-title":"Vancomycin and the red-man syndrome: pharmacodynamics of histamine release.","volume":"157","author":"Polk","year":"1988","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"R15-9-20210202","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1007\/s00011-004-0426-6","article-title":"Characterisation of functional polymorphisms of the human diamine oxidase gene.","volume":"54","author":"Petersen","year":"2005","journal-title":"Inflamm Res"},{"key":"R16-9-20210202","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000237129","article-title":"Mucosal histamine content and histamine secretion in Crohns disease, ulcerative colitis and allergic enteropathy.","volume":"108","author":"Raithel","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"R17-9-20210202","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00008571-200004000-00007","article-title":"Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma.","volume":"10","author":"Yan","year":"2000","journal-title":"Pharmacogenetics"},{"key":"R18-9-20210202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0031-6997(25)00016-X","article-title":"Inflammatory mediators and asthma.","volume":"40","author":"Barnes","year":"1988","journal-title":"Pharmacol Rev"},{"key":"R19-9-20210202","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF02026434","article-title":"Histamine and its metabolism in mammalsPart II: Catabolism of histamine and histamine liberation.","volume":"5","author":"Maslinski","year":"1975","journal-title":"Agents Actions"},{"key":"R20-9-20210202","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00008571-200307000-00004","article-title":"Histamine N-methyltransferase gene polymorphisms in Chinese and their relationship with enzyme activity in erythrocytes.","volume":"13","author":"Chen","year":"2003","journal-title":"Pharmacogenetics"},{"key":"R21-9-20210202","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2217\/pgs.09.26","article-title":"Histamine pharmacogenomics.","volume":"10","author":"Garcia-Martin","year":"2009","journal-title":"Pharmacogenomics"},{"key":"R22-9-20210202","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3346\/jkms.2005.20.3.367","article-title":"Polymorphisms of high-affinity IgE receptor and histamine-related genes in patients with ASA-induced urticariaangioedema.","volume":"20","author":"Choi","year":"2005","journal-title":"J Korean Med Sci"},{"key":"R23-9-20210202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2465","article-title":"The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines.","volume":"7","author":"Thurmond","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"R24-9-20210202","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1542\/peds.107.6.e99","article-title":"Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services.","volume":"107","author":"Feudtner","year":"2001","journal-title":"Pediatrics"},{"key":"R26-9-20210202","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/bioinformatics\/btf869","article-title":"Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions.","volume":"19","author":"Hahn","year":"2003","journal-title":"Bioinformatics"},{"key":"R27-9-20210202","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/ACI.0b013e32833bfa20","article-title":"Recent advances in antileukotriene therapy.","volume":"10","author":"Scadding","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R28-9-20210202","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1468-3083.2001.00278.x","article-title":"The use of antidepressant drugs in dermatology.","volume":"15","author":"Gupta","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R29-9-20210202","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1128\/AAC.34.4.550","article-title":"Vancomycin-induced histamine release and red man syndrome: comparison of 1- and 2-hour infusions.","volume":"34","author":"Healy","year":"1990","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-201205000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T08:01:37Z","timestamp":1742457697000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201205000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31824e10d7","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}